QUERCETIN AS THERAPEUTIC SOURCE FOR OVARIAN, UTERINE, AND HEPATO-RENAL PROFILE OF SPRAGUE DAWLEY RATS WITH LETROZOLE-INDUCED POLYCYSTIC OVARIAN SYNDROME
Main Article Content
Keywords
Polycystic ovary syndrome, Quercetin, Metformin
Abstract
Females of reproductive age are affected by Polycystic ovary syndrome (PCOS) all over the world.Traditional methods of treatment like metformin don,t provide cure but just symptomatic relieve and with many side effects. Current study compared the results in terms of improving the hormonal, biochemical, enzymatic, and histopathological profile along with nephro- renal protective activity in PCOS induced rat models, after treatment with quercetin, (50 mg/kg) in Letrozole (1.0 mg/Kg b. w./day) induced PCOS female Sprague Dawley rats (150-200gm) by keeping metformin (50 mg/Kg b.w.) as positive control. Statistically analyzed results (p<0.0001) showed that LH, homeostatic model assessment insulin resistance (HOMA-IR), AST, bilirubin and uric acid decreased in PCOS rats after treatment with quercetin, (0.8±0.05ng/dL, 0.07±0.05, 55.6 ±4.0 IU/L, 0.2 ±3.3 mg/dL and 2.3±0.7 mg/dL) as compared to control (2.09 ± 0.08 ng/dL, 0.12 ± 0.01, 181.3 ± 32.0 IU/L, 0.2 ± 0.1 mg/dL, 4.7 ± 0.15 mg/dL) respectively. Restoration in progesterone and estrogen were found significant in experimental groups (13.4±2.3 pg/dL, 53.5± 1.5pg/m\L) as compared to control (9.05±1.2pg/dL, 48± 5.2pg/mL) respectively with restoration of normal ovarian stroma from typical pearl string cystic appearance and normal hepato-renal tissues in histology. So it is concluded that quercetin, can be helpful to cure or mange PCOS .
References
2. Bulsara J, Patel P, Soni A, Acharya S. A review: Brief insight into Polycystic Ovarian syndrome. Endocrine and Metabolic Science. 2021 Jun 30; 3:100085.Glueck, C. J., & Goldenberg, N. (2019). Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism, 92, 108-120
3. Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: pathophysiology, presentation, andtreatment with emphasis on adolescent girls. Journal of the Endocrine Society. 2019 Aug; 3(8):1545-73.
4. Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., ... & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature reviews Disease primers, 2(1), 1-18
5. Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ. Polycystic ovary syndrome. The Lancet Diabetes & Endocrinology. 2022 Aug 4.
6. Gholamali. J, Kobra. A. (2012). Effect of Vitexagnus-castus fruits hydro alcoholic extract on sex hormones in rat with induced polycystic ovary syndrome (PCOS). Physiol. Pharmacol, 16, 62-69.
7. Jiang, S., Tang, T., Sheng, Y., Li, R., & Xu, H. (2022). The Effects of Letrozole and Metformin Combined with Targeted Nursing Care on Ovarian Function, LH, and FSH in Infertile Patients with Polycystic Ovary Syndrome. Journal of Healthcare Engineering, 2022.
8. Garzia, E., Galiano, V., Marfia, G., Navone, S., Grossi, E., & Marconi, A. M. (2022). Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients. Reproductive Biology and Endocrinology, 20(1), 1-12.
9. Al Khalifah, R. A., Florez, I. D., Dennis, B., Thabane, L., & Bassilious, E. (2016). Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Pediatrics, 137(5).
10. Nasri H, Rafieian-Kopaei M. Metformin: Current knowledge. J Res Med Sci. 2014 Jul;19(7):658-64. PMID: 25364368; PMCID: PMC4214027.
11. Rosenfield, R. L., & Ehrmann, D. A. (2016). The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine reviews, 37(5), 467-520.
12. David, A. V. A., Arulmoli, R., & Parasuraman, S. (2016). Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacognosy reviews, 10(20), 84.
13. Ay, M., Luo, J., Langley, M., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2017). Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease. Journal of neurochemistry, 141(5), 766-782.
14. Alkalby, J., & Hamzah, F. (2017). Ameliorative effect of fenugreek on sex hormones in polycystic ovary syndrome female rats induced by letrozole. Kufa Journal For Veterinary Medical Sciences, 8(2).
15. Fatima, H., Shahid, M., Jamil, A., & Naveed, M. (2021). Therapeutic Potential of Selected Medicinal Plants Against Carrageenan Induced Inflammation in Rats. Dose-Response, 19(4),
16. Oza, M. J., & Kulkarni, Y. A. (2019). Formononetin attenuates kidney damage in type 2 diabetic rats. Life sciences, 219, 109-121
17. Ajayi, A. F., & Akhigbe, R. E. (2020). Staging of the estrous cycle and induction of estrus in experimental rodents: an update. Fertility research and practice, 6(1), 1-15.
18. Elmlinger, M. W. (2011). Laboratory measurements of hormones and related biomarkers: technologies, quality management and validation. Diagnostics of endocrine function in children and adolescents. Basel: Karger Publications, 1-31
19. Jiang, S., Tang, T., Sheng, Y., Li, R., & Xu, H. (2022). The Effects of Letrozole and Metformin Combined with Targeted Nursing Care on Ovarian Function, LH, and FSH in Infertile Patients with Polycystic Ovary Syndrome. Journal of Healthcare Engineering, 2022.
20. Arentz, S., Smith, C. A., Abbott, J., & Bensoussan, A. (2017). Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis. BMC complementary and alternative medicine, 17(1), 1-14.
21. Maharjan, R., Nagar, P. S., & Nampoothiri, L. (2010). Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat model. Journal of Ayurveda and integrative medicine, 1(4), 273
22. Wang, Y. W., He, S. J., Feng, X., Cheng, J., Luo, Y. T., Tian, L., & Huang, Q. (2017). Metformin: a review of its potential indications. Drug design, development and therapy, 11, 2421
23. Banaszewska, B., Wrotyńska-Barczyńska, J., Spaczynski, R. Z., Pawelczyk, L., & Duleba, A. J. (2016). Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. The Journal of Clinical Endocrinology & Metabolism, 101(11), 4322-4328.
24. Jahan, S., Abid, A., Khalid, S., Afsar, T., Shaheen, G., Almajwal, A., & Razak, S. (2018). Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study. Journal of ovarian research, 11(1), 1-10.
25. Shah, K. N., & Patel, S. S. (2016). Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome. Pharmaceutical biology, 54(6), 975-983.
26. Gharia, B., Seegobin, K., Maharaj, S., Marji, N., Deutch, A., & Zuberi, L. (2017). Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature. Oxford Medical Case Reports, 2017(11).
27. Puri, P., & Jiang, S. (2020, November). Letrozole-induced acute interstitial nephritis. in nephrology (vol. 25, pp. 60-60). 111 river st, hoboken 07030-5774, nj usa: wiley.
28. Zhao, X., Wang, J., Deng, Y., Liao, L., Zhou, M., Peng, C., & Li, Y. (2021). Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism. Phytotherapy Research, 35(9), 4727-4747.
29. Yang, H., Song, Y., Liang, Y. N., & Li, R. (2018). Quercetin treatment improves renal function and protects the kidney in a rat model of adenine-induced chronic kidney disease. Medical science monitor: international medical journal of experimental and clinical research, 24, 4760.
30. Neisy, A., Zal, F., Seghatoleslam, A., & Alaee, S. (2019). Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS). Reproduction, Fertility and Development, 31(2), 315-323.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Ghazala Waris
Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore - Pakistan.
Asma Ahmed
Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore - Pakistan.
Rehana Badar
Department of Biological Sciences Superior University Lahore - Pakistan
Samra Hafeez
Sharif Medical and Dental College, Lahore - Pakistan.
Hasan Akbar Khan
Department of Biochemistry, Gulab Devi Medical Complex, Lahore - Pakistan.